186 related articles for article (PubMed ID: 31600027)
1. Using biologically based objectives to optimize boost intensity-modulated radiation therapy planning for brainstem tumors in dogs.
Meier V; Besserer J; Rohrer Bley C
Vet Radiol Ultrasound; 2020 Jan; 61(1):77-84. PubMed ID: 31600027
[TBL] [Abstract][Full Text] [Related]
2. Risk adaptive planning with biology-based constraints may lead to higher tumor control probability in tumors of the canine brain: A planning study.
Radonic S; Schneider U; Besserer J; Meier VS; Rohrer Bley C
Phys Med; 2024 Mar; 119():103317. PubMed ID: 38430675
[TBL] [Abstract][Full Text] [Related]
3. Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors.
Thomas E; Chapet O; Kessler ML; Lawrence TS; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):571-8. PubMed ID: 15890602
[TBL] [Abstract][Full Text] [Related]
4. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
[TBL] [Abstract][Full Text] [Related]
5. Potential for intensity-modulated radiation therapy to permit dose escalation for canine nasal cancer.
Vaudaux C; Schneider U; Kaser-Hotz B
Vet Radiol Ultrasound; 2007; 48(5):475-81. PubMed ID: 17899986
[TBL] [Abstract][Full Text] [Related]
6. A prospective pilot study on early toxicity from a simultaneously integrated boost technique for canine sinonasal tumours using image-guided intensity-modulated radiation therapy.
Soukup A; Meier V; Pot S; Voelter K; Rohrer Bley C
Vet Comp Oncol; 2018 Dec; 16(4):441-449. PubMed ID: 29761663
[TBL] [Abstract][Full Text] [Related]
7. The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study.
Wu Q; Manning M; Schmidt-Ullrich R; Mohan R
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):195-205. PubMed ID: 10656393
[TBL] [Abstract][Full Text] [Related]
8. Voxel-Level BED Corrected Dosimetric and Radiobiological Assessment of 2 Kinds of Hybrid Radiotherapy Planning Methods for Stage III NSCLC.
Wang H; Huang Y; Chen H; Shao Y; Duan Y; Feng A; Gu H; Ma X; Xu Z; Kong Q; Zhou Y
Technol Cancer Res Treat; 2022; 21():15330338221107966. PubMed ID: 35731648
[No Abstract] [Full Text] [Related]
9. Definitive-intent intensity-modulated radiation therapy provides similar outcomes to those previously published for definitive-intent three-dimensional conformal radiation therapy in dogs with primary brain tumors: A multi-institutional retrospective study.
Van Asselt N; Christensen N; Meier V; Rohrer Bley C; Laliberte S; Poirier VJ; Desai N; Chen Y; Turek M
Vet Radiol Ultrasound; 2020 Jul; 61(4):481-489. PubMed ID: 32356907
[TBL] [Abstract][Full Text] [Related]
10. Reducing margins for abdominopelvic tumours in dogs: Impact on dose-coverage and normal tissue complication probability.
Meier V; Staudinger C; Radonic S; Besserer J; Schneider U; Walsh L; Rohrer Bley C
Vet Comp Oncol; 2021 Jun; 19(2):266-274. PubMed ID: 33372354
[TBL] [Abstract][Full Text] [Related]
11. Assessment and quantification of patient set-up errors in nasopharyngeal cancer patients and their biological and dosimetric impact in terms of generalized equivalent uniform dose (gEUD), tumour control probability (TCP) and normal tissue complication probability (NTCP).
Boughalia A; Marcie S; Fellah M; Chami S; Mekki F
Br J Radiol; 2015 Jun; 88(1050):20140839. PubMed ID: 25882689
[TBL] [Abstract][Full Text] [Related]
12. Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP.
Jingu K; Ariga H; Kaneta T; Takai Y; Takeda K; Katja L; Narazaki K; Metoki T; Fujimoto K; Umezawa R; Ogawa Y; Nemoto K; Koto M; Mitsuya M; Matsufuji N; Takahashi S; Yamada S
BMC Cancer; 2010 Apr; 10():127. PubMed ID: 20374623
[TBL] [Abstract][Full Text] [Related]
13. Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions.
Spalding AC; Jee KW; Vineberg K; Jablonowski M; Fraass BA; Pan CC; Lawrence TS; Haken RK; Ben-Josef E
Med Phys; 2007 Feb; 34(2):521-9. PubMed ID: 17388169
[TBL] [Abstract][Full Text] [Related]
14.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
15. Simultaneous integrated intensity-modulated radiotherapy boost for locally advanced gynecological cancer: radiobiological and dosimetric considerations.
Guerrero M; Li XA; Ma L; Linder J; Deyoung C; Erickson B
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):933-9. PubMed ID: 15936580
[TBL] [Abstract][Full Text] [Related]
16. Treatment of pancreatic cancer tumors with intensity-modulated radiation therapy (IMRT) using the volume at risk approach (VARA): employing dose-volume histogram (DVH) and normal tissue complication probability (NTCP) to evaluate small bowel toxicity.
Landry JC; Yang GY; Ting JY; Staley CA; Torres W; Esiashvili N; Davis LW
Med Dosim; 2002; 27(2):121-9. PubMed ID: 12074463
[TBL] [Abstract][Full Text] [Related]
17. A complication probability study for a definitive-intent, moderately hypofractionated image-guided intensity-modulated radiotherapy protocol for anal sac adenocarcinoma in dogs.
Meier V; Besserer J; Roos M; Rohrer Bley C
Vet Comp Oncol; 2019 Mar; 17(1):21-31. PubMed ID: 30136336
[TBL] [Abstract][Full Text] [Related]
18. Escalation of radiotherapy dose in large locally advanced drug-resistant gastrointestinal stromal tumors by multi-shell simultaneous integrated boost intensity-modulated technique: a feasibility study.
Cui H; Li Y; Huang W; Lu W; Yi X
Radiat Oncol; 2022 Dec; 17(1):216. PubMed ID: 36578008
[TBL] [Abstract][Full Text] [Related]
19. Esophagus sparing with IMRT in lung tumor irradiation: an EUD-based optimization technique.
Chapet O; Thomas E; Kessler ML; Fraass BA; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):179-87. PubMed ID: 16111587
[TBL] [Abstract][Full Text] [Related]
20. Influence of organ motion on conformal vs. intensity-modulated pelvic radiotherapy for prostate cancer.
Hysing LB; Skorpen TN; Alber M; Fjellsbø LB; Helle SI; Muren LP
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1496-503. PubMed ID: 18538493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
